2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Рекомендации ESC 2021 года по профилактике сердечно-сосудистых заболеваний в клинической практике
2021-08-30
SCID: 54.1/8u5ewj76
Discuss with AI
ESC Guidelinescardiovascular disease preventionclinical practicepreventive strategiestherapeutic strategies
Figures from the paper
Abstract (AI)
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication. The ESC is not responsible in the event of any contradiction, discrepancy and/or ambiguity between the ESC Guidelines and any other official recommendations or guidelines issued by the relevant public health authorities, in particular in relation to good use of healthcare or therapeutic strategies. Health professionals are encouraged to take the ESC Guidelines fully into account when exercising their clinical judgment, as well as in the determination and the implementation of preventive, diagnostic or therapeutic medical strategies; however, the ESC Guidelines do not override, in any way whatsoever, the individual responsibility of health professionals to make appropriate and accurate decisions in consideration of each patient's health condition and in consultation with that patient and, where appropriate and/or necessary, the patient's caregiver. Nor do the ESC Guidelines exempt health professionals from taking into full and careful consideration the relevant official updated recommendations or guidelines issued by the competent public health authorities, in order to manage each patient's case in light of the scientifically accepted data pursuant to their respective ethical and professional obligations. It is also the health professional's responsibility to verify the applicable rules and regulations relating to drugs and medical devices at the time of prescription.
Key Findings
1
Clinical professionals should integrate the guidelines into preventive, diagnostic, and therapeutic decisions while applying individualized clinical judgment.
2
Clinicians must verify current rules and regulations governing drugs and medical devices when prescribing them.
3
The 2021 ESC Guidelines provide evidence-informed recommendations for preventing cardiovascular disease in clinical practice.
4
The guidelines do not supersede official public-health recommendations, healthcare regulations, or the clinician’s responsibility to consult patients and caregivers.
5
The guidelines reflect scientific and medical knowledge and evidence available at the time of publication.
Research Object
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Research Subject
evidence-based preventive, diagnostic, and therapeutic strategies and their clinical implementation
Publication Details
Publication Date
2021-08-30
Journal
Publisher
ISSN
Cited by
38
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 20172018
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation2015
Exercise-based cardiac rehabilitation for coronary heart disease2011
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes2008